Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Update

Sharps Technology, Inc. (NASDAQ:STSS) was the recipient of a significant increase in short interest in February. As of February 15th, there was short interest totalling 899,200 shares, an increase of 110.0% from the January 31st total of 428,100 shares. Based on an average daily volume of 3,140,000 shares, the short-interest ratio is presently 0.3 days. Approximately 70.3% of the shares of the stock are short sold.

Institutional Trading of Sharps Technology

Hedge funds and other institutional investors have recently bought and sold shares of the business. Anson Funds Management LP purchased a new position in shares of Sharps Technology during the fourth quarter valued at $76,000. Essential Planning LLC. increased its stake in shares of Sharps Technology by 22.7% during the fourth quarter. Essential Planning LLC. now owns 199,854 shares of the company’s stock valued at $412,000 after buying an additional 37,029 shares during the period. Finally, Garden State Investment Advisory Services LLC purchased a new position in shares of Sharps Technology during the third quarter valued at $26,000. Hedge funds and other institutional investors own 17.17% of the company’s stock.

Sharps Technology Stock Down 6.3 %

Shares of NASDAQ:STSS traded down $0.02 during trading on Friday, reaching $0.28. The company’s stock had a trading volume of 1,752,872 shares, compared to its average volume of 5,126,340. The company’s 50 day moving average price is $1.19. Sharps Technology has a 12 month low of $0.26 and a 12 month high of $18.15. The stock has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.41.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.